PHARMACEUTICAL COMPOSITION COMPRISING RIVOCERANIB FOR INHIBITION OF OCULAR NEOVASCULARIZATION AND METHOD FOR INHIBITING OCULAR NEOVASCULARIZATION BY USING SAME

摘要

The present invention relates to a pharmaceutical composition comprising rivoceranib for inhibition of ocular neovascularization and a method for inhibiting ocular neovascularization by using same. An eye drop comprising rivoceranib as an active ingredient reduces a neovascularized corneal area and vascularity index in an animal model and the number and area of vessels and lymphatic ducts in corneal tissues and as such, can be effectively used for inhibiting corneal neovascularization.